Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Bull Soc Pathol Exot ; 111(1): 24-30, 2018.
Article in French | MEDLINE | ID: mdl-30763499

ABSTRACT

The aim of this work is to study the epidemiology of central neurological system (CNS) diagnosed in the population of people living with HIV in the department of infectious diseases in UHC Ibn Rochd of Casablanca from January 2005 to May 2015. The demographic and clinical profile along with the outcome of these patients were studied. The data were collected from Nadis software. Three hundred and eighty-seven patients were admitted for CNS diagnosis, out of 3496 people living with HIV admitted during this time period, i.e., a prevalence of 11%. The sex ratio (M/F) was 1.27. The average age was 39 years (± 7). Neurological involvement was indicative of HIV infection in 225 cases (68.8%). Neurological disorders were dominated by headache (70%), focal neurological syndrome (35%), and meningeal syndrome (30%). CNS diagnosis noted were CNS tuberculosis (37%), cerebral toxoplasmosis (30%), and cryptococcal meningitis (20%). The median CD4 T-lymphocyte was 184 cells/mm3. Infection with severe immunosuppression was progressive multifocal leucoencephalitis, cryptococcal meningitis, and primary cerebral lymphoma. Lethality was 39%. In the department of infectious diseases of the UHC, the main cause of death among HIV-infected patients is tuberculosis. Collaboration between the national tuberculosis and AIDS programs has been established to improve the detection and management of these patients.


L'objectif de ce travail est d'étudier l'épidémiologie des manifestations neurologiques centrales (MNC) des patients vivant avec le VIH (PvVIH) suivis dans le service des maladies infectieuses du CHU Ibn Rochd de Casablanca entre janvier 2005 et mai 2015. La source des données était le logiciel Nadis. Trois cent quatre-vingt-sept patients ont été hospitalisés pour une MNC sur 3 496 PvVIH, soit une prévalence de 11 %. Le sex-ratio (H/F) était de 1,27. L'âge moyen des patients était de 39 ans (± 7). L'atteinte neurologique était révélatrice de l'infection à VIH dans 266 cas (69 %). Les troubles neurologiques étaient dominés par les céphalées (70 %), le syndrome neurologique focal (35 %) et le syndrome méningé (35 %). Les étiologies étaient dominées par la méningoencéphalite tuberculeuse (37 %), la toxoplasmose cérébrale (30 %) et la cryptococcose neuroméningée (CNM) (20 %). La médiane des lymphocytes T CD4 était de 184 cellules/mm3. Les atteintes survenues en cas d'immunodépression sévère étaient la leucoencéphalite multifocale progressive, la CNM et le lymphome cérébral primitif. Le taux de létalité global était de 39 %. Dans le service des maladies infectieuses du CHU prenant en charge les PvVIH, la tuberculose est la première étiologie des MNC au cours de l'infection au VIH. Une collaboration conjointe du programme national de lutte contre la tuberculose et de celui de lutte contre le sida a été mise en place pour améliorer le dépistage et la prise en charge de ces patients.


Subject(s)
AIDS-Related Opportunistic Infections/epidemiology , Central Nervous System Viral Diseases/epidemiology , HIV Infections/epidemiology , Nervous System Diseases/epidemiology , Adult , Aged , Central Nervous System Viral Diseases/complications , Female , HIV , HIV Infections/complications , Hospitals, University , Humans , Male , Middle Aged , Morocco/epidemiology , Nervous System Diseases/virology , Retrospective Studies
2.
Rev Pneumol Clin ; 68(1): 36-9, 2012 Feb.
Article in French | MEDLINE | ID: mdl-22056792

ABSTRACT

The occurrence of invasive pulmonary aspergillosis is unusual during the course of AIDS. Patients at risk have a CD4 T-lymphocyte count under 50 cells/mm(3) combined with other risk factors in 50% of the cases. Positive diagnosis is based on chest CT scan imaging and isolation of Aspergillus in broncho-alveolar fluid. Detection of galactomannan antigen in serum and broncho-alveolar lavage fluid (BALF) is a reliable complementary tool in assessing the diagnosis. The first line therapy is Voriconazole. The prognosis, often severe, depends on prompt initiation of the appropriate antifungal treatment. We report two cases of invasive pulmonary aspergillosis in AIDS patients.


Subject(s)
Antifungal Agents/therapeutic use , Aspergillosis/diagnosis , HIV Infections/complications , Lung Diseases, Fungal/diagnosis , Pulmonary Aspergillosis/complications , Pyrimidines/therapeutic use , Triazoles/therapeutic use , Adult , Aspergillosis/diagnostic imaging , Bronchoalveolar Lavage , HIV Infections/diagnosis , Humans , Lung Diseases, Fungal/diagnostic imaging , Lung Diseases, Fungal/drug therapy , Male , Middle Aged , Prognosis , Pulmonary Aspergillosis/diagnosis , Radiography , Risk Factors , Voriconazole
SELECTION OF CITATIONS
SEARCH DETAIL
...